Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

The impact of translational research on gastroenterology.

Di Sabatino A, Moschetta A, Conte D, Tiribelli C; Translational Committee of the Italian Society of Gastroenterology, Caprioli FA, Fabris L, Fantini MC, Frulloni L, Monteleone G, Romano M, Sarnelli G, Baroni GS.

Dig Liver Dis. 2014 Apr;46(4):293-4. doi: 10.1016/j.dld.2013.12.015. Epub 2014 Feb 5. No abstract available.

PMID:
24508099
2.

[New therapies of chronic inflammatory bowel disease: anti-TNF antibodies and probiotics. The Danish Society of Gastroenterology].

Kjeldsen J, Brynskov J, Madsen JR.

Ugeskr Laeger. 2001 Mar 19;163(12):1707. Danish. No abstract available.

PMID:
11284407
3.

Anti-TNF and skin inflammation in IBD: a new paradox in gastroenterology?

Niess JH, Danese S.

Gut. 2014 Apr;63(4):533-5. doi: 10.1136/gutjnl-2013-304683. Epub 2013 Apr 9. No abstract available.

PMID:
23570743
4.

Biomarker and drug discovery for gastroenterology through translational bioinformatics.

Dudley JT, Butte AJ.

Gastroenterology. 2010 Sep;139(3):735-41, 741.e1. doi: 10.1053/j.gastro.2010.07.024. Epub 2010 Jul 19. Review. No abstract available.

PMID:
20650279
5.

Smad7 antisense oligonucleotide-based therapy for inflammatory bowel diseases.

Zorzi F, Angelucci E, Sedda S, Pallone F, Monteleone G.

Dig Liver Dis. 2013 Jul;45(7):552-5. doi: 10.1016/j.dld.2012.11.011. Epub 2013 Jan 1. Review.

PMID:
23287011
6.

New mechanisms and targets for IBD Therapy: translational gastroenterology comes of age.

Danese S, Peyrin-Biroulet L.

Curr Drug Targets. 2013 Nov;14(12):1377-8. No abstract available.

PMID:
24060146
7.

New and emerging therapies for inflammatory bowel diseases.

Grimm MC.

J Gastroenterol Hepatol. 2009 Oct;24 Suppl 3:S69-74. doi: 10.1111/j.1440-1746.2009.06074.x. Review.

PMID:
19799702
8.

T3 translational science in gastroenterology: getting to best outcomes.

Crandall W.

Clin Gastroenterol Hepatol. 2013 Dec;11(12):1559-61. doi: 10.1016/j.cgh.2013.10.001. Epub 2013 Oct 6. Review.

PMID:
24107397
9.

Interleukin-25 production is differently regulated by TNF-α and TGF-β1 in the human gut.

Fina D, Franzè E, Rovedatti L, Corazza GR, Biancone L, Sileri PP, Sica G, MacDonald TT, Pallone F, Di Sabatino A, Monteleone G.

Mucosal Immunol. 2011 Mar;4(2):239-44. doi: 10.1038/mi.2010.68. Epub 2010 Oct 13.

PMID:
20944558
10.

TGF-beta1 and Smad7 in the regulation of IBD.

Monteleone G, Boirivant M, Pallone F, MacDonald TT.

Mucosal Immunol. 2008 Nov;1 Suppl 1:S50-3. doi: 10.1038/mi.2008.55. Review.

PMID:
19079231
12.

[Chronic inflammatory bowel disease - new therapies: tumor necrosis factor-antibodies and cytokines].

Stange EF.

Z Gastroenterol. 2002 Apr;40 Suppl 1:S90-S1. German.

PMID:
11930299
13.

Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease.

Monteleone G, Kumberova A, Croft NM, McKenzie C, Steer HW, MacDonald TT.

J Clin Invest. 2001 Aug;108(4):601-9.

14.

Mechanisms of action of infliximab in inflammatory bowel disease: an anti-inflammatory multitasker.

Danese S.

Dig Liver Dis. 2008 Jul;40 Suppl 2:S225-8. doi: 10.1016/S1590-8658(08)60530-7.

PMID:
18598993
15.

Monoclonal antibody therapy in inflammatory bowel disease.

Vasiliauskas EA.

Nestle Nutr Workshop Ser Clin Perform Programme. 1999;2:237-52; discussion 253-5. Review. No abstract available.

PMID:
11490626
16.

Using plasma vitamin D concentration as a surrogate marker to predict drug response: a new chapter in the management of inflammatory bowel disease and beyond?

Chan LN, Paski SC.

JPEN J Parenter Enteral Nutr. 2014 Mar-Apr;38(3):279-80. doi: 10.1177/0148607114525470. No abstract available.

PMID:
24590306
17.

[Immunology in medical practice. IV. Inflammatory bowel diseases: pathogenic starting points for specific therapy].

van Deventer SJ.

Ned Tijdschr Geneeskd. 1997 Oct 11;141(41):1956-9. Review. Dutch.

PMID:
9550744
18.

Inflammatory bowel disease--live transmission.

Hecht GA.

N Engl J Med. 2008 Jan 31;358(5):528-30. doi: 10.1056/NEJMcibr0707718. No abstract available.

PMID:
18234759
19.

Practical guidelines for treating inflammatory bowel disease safely with anti-tumour necrosis factor therapy in Australia.

Connell W, Andrews JM, Brown S, Sparrow M.

Intern Med J. 2010 Feb;40(2):139-49. doi: 10.1111/j.1445-5994.2009.02122.x.

PMID:
20446955
20.

Single-nucleotide polymorphisms in inflammatory bowel disease.

Neuman MG, Nanau RM.

Transl Res. 2012 Jul;160(1):45-64. doi: 10.1016/j.trsl.2011.10.006. Epub 2011 Nov 23. Review.

PMID:
22687962

Supplemental Content

Support Center